#Parkinson's disease

Novo Nordisk hands shelved Parkinson’s cell therapy to Zuckerberg-backed Cellular Intelligence

Novo Nordisk has handed over its discontinued Parkinson’s therapy STEM-PD to AI biotech startup Cellular Intelligence, in a deal that includes equity stakes and future milestone payments.